Discover updated COVID-19 testing guidelines, including when to test and which types are recommended. Learn about rapid testing and its role in disease prevention.
Currently browsing: Government
ASSURE In the News
Vaccine Safety: Are the Latest COVID-19 Vaccines Safe, and What Are Their Potential Side Effects?
Learn about the safety of the latest COVID-19 vaccines, their potential side effects, and the importance of vaccination and testing in preventing SARS-CoV-2.
COVID Mask Usage: Are Masks Still Recommended?
Learn when and why masks are recommended in 2024-2025 to prevent COVID-19 spread. Discover guidelines, mask types, and the role of rapid testing in prevention.
COVID-19 in 2025 and the New Trump Administration: Policy Shifts and Public Health Implications
Explore how the Trump administration’s 2025 policies are reshaping COVID-19 management, focusing on rapid testing initiatives and changes in vaccination strategies.
New and Emerging Variants of COVID-19 in 2025
Stay informed about the latest COVID-19 variants, including XEC, KP.3.1.1, and JN.1. Learn how they differ from earlier strains in terms of transmissibility, immune evasion, and clinical severity, and understand their implications for public health measures.
Guidelines for COVID-19 Vaccinations and Booster Shots in 2024
Stay informed about the latest COVID-19 vaccination guidelines, including booster shot recommendations, to protect yourself and your community.
PRESS RELEASE | Free ASSURE-100 Rapid Tests for Kūpuna and At-Risk Hawai’i Residents as Federal Support Ends
On May 11 the US government will end the COVID-19 Public Health Emergency covering free Covid-19 tests. In response, Oceanit plans to give free ASSURE-100 rapid tests to Hawaii Kūpuna and residents who are at high risk for adverse effects from Covid-19.
IN THE NEWS | FDA Roundup: December 23, 2022
On December 23, the U.S. Food and Drug Administration provided an “at-a-glance summary” of news from around the agency, which included the over-the-counter EUA for ASSURE-100 Rapid COVID-19 At-Home Tests.
PRESS RELEASE | Oceanit Receives FDA Emergency Use Authorization for ASSURE-100 Rapid COVID-19 Tests
Oceanit receives U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the ASSURE-100 rapid antigen test for detection of COVID-19.
PRESS RELEASE | National Institutes of Health Approves Next Round of ASSURE-19 Funding Under the RADx ‘Next’ Program
Oceanit Laboratories received approval from NIH for next round funding under the RADx initiative, receiving an additional $250,000 for further development of the ASSURE-19 rapid Covid-19 saliva test. With this latest round of funding, Oceanit will have access to additional NIH R&D resources through the RADx network of core partners, which can help to expedite moving ASSURE-19 to market.